169 related articles for article (PubMed ID: 34678509)
1. The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Durdagi S; Avsar T; Orhan MD; Serhatli M; Balcioglu BK; Ozturk HU; Kayabolen A; Cetin Y; Aydinlik S; Bagci-Onder T; Tekin S; Demirci H; Guzel M; Akdemir A; Calis S; Oktay L; Tolu I; Butun YE; Erdemoglu E; Olkan A; Tokay N; Işık Ş; Ozcan A; Acar E; Buyukkilic S; Yumak Y
Mol Ther; 2022 Feb; 30(2):963-974. PubMed ID: 34678509
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Eur J Pharmacol; 2021 Apr; 896():173922. PubMed ID: 33539819
[TBL] [Abstract][Full Text] [Related]
4. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
5. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent small molecule inhibitors of SARS-CoV-2 entry.
Mediouni S; Mou H; Otsuka Y; Jablonski JA; Adcock RS; Batra L; Chung DH; Rood C; de Vera IMS; Rahaim R; Ullah S; Yu X; Getmanenko YA; Kennedy NM; Wang C; Nguyen TT; Hull M; Chen E; Bannister TD; Baillargeon P; Scampavia L; Farzan M; Valente ST; Spicer TP
SLAS Discov; 2022 Jan; 27(1):8-19. PubMed ID: 35058179
[TBL] [Abstract][Full Text] [Related]
7. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
Choi Y; Shin B; Kang K; Park S; Beck BR
Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
[TBL] [Abstract][Full Text] [Related]
8. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.
Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
[TBL] [Abstract][Full Text] [Related]
11. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
13. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
Zhang J; Huang F; Xia B; Yuan Y; Yu F; Wang G; Chen Q; Wang Q; Li Y; Li R; Song Z; Pan T; Chen J; Lu G; Zhang H
Signal Transduct Target Ther; 2021 May; 6(1):189. PubMed ID: 33980808
[TBL] [Abstract][Full Text] [Related]
14. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.
Chen Y; Lear TB; Evankovich JW; Larsen MB; Lin B; Alfaras I; Kennerdell JR; Salminen L; Camarco DP; Lockwood KC; Tuncer F; Liu J; Myerburg MM; McDyer JF; Liu Y; Finkel T; Chen BB
Nat Commun; 2021 Jun; 12(1):3907. PubMed ID: 34162861
[TBL] [Abstract][Full Text] [Related]
16. Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir.
Behera SK; Vhora N; Contractor D; Shard A; Kumar D; Kalia K; Jain A
Sci Rep; 2021 Mar; 11(1):7307. PubMed ID: 33790352
[TBL] [Abstract][Full Text] [Related]
17. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
[TBL] [Abstract][Full Text] [Related]
18. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells.
Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289
[TBL] [Abstract][Full Text] [Related]
19. Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion.
Kaur U; Chakrabarti SS; Ojha B; Pathak BK; Singh A; Saso L; Chakrabarti S
Curr Drug Targets; 2021; 22(2):192-201. PubMed ID: 32972339
[TBL] [Abstract][Full Text] [Related]
20. Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights.
Borisevich SS; Khamitov EM; Gureev MA; Yarovaya OI; Rudometova NB; Zybkina AV; Mordvinova ED; Shcherbakov DN; Maksyutov RA; Salakhutdinov NF
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
